ProCE Banner Activity

PARP Inhibitor–Associated Adverse Events: Identification and Management

Slideset Download
In this downloadable slideset, CCO’s expert faculty reviews PARP inhibitor-associated adverse events, including identification and their management in newly diagnosed ovarian cancer.

Released: December 22, 2020

Expiration: December 21, 2021

No longer available for credit.

Share

Faculty

Prof Jonathan A. Ledermann

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci

Professor of Medical Oncology
CRUK and UCL Cancer Trials Centre
UCL Cancer Institute
Honorary Consultant in Medical Oncology
Cancer Services
UCL Hospitals
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci

Professor of Medical Oncology
CRUK and UCL Cancer Trials Centre
UCL Cancer Institute
Honorary Consultant in Medical Oncology
Cancer Services
UCL Hospitals
London, United Kingdom